<DOC>
	<DOCNO>NCT01901705</DOCNO>
	<brief_summary>Psoriasis common , chronic skin disease remissive , oppose curative , treatment available . Traditional Chinese medicine one frequently choose alternative therapy China Taiwan , psoriasis treat century topical oral herbal preparation . Topical indigo naturalis ointment report exhibit potential anti-psoriatic efficacy . The study objective investigate pharmacological effect explore target mechanisms Traditional Chinese Medicine ( TCM ) Indigo Naturalis topical ointment single treatment agent Chinese subject mild moderate plaque-type Psoriasis . This single site , randomize , double-blinded , placebo control study topical indigo naturalis vs. vehicle alone ( placebo ) treat mild moderate plaque-type psoriasis 8-week period . Pharmacological effect evaluate biomarker evaluation clinical evaluation . The trial conduct China Medical University Hospital ( CMUH ) , Taichung , Taiwan . All patient provide write informed consent inclusion study . The study protocol approve institutional review board ( IRB ) CMUH .</brief_summary>
	<brief_title>A Study Topical Indigo Naturalis Treatment Patients With Mild Moderate Plaque-type Psoriasis</brief_title>
	<detailed_description>Estimated enrollment : Total 24 subject : mild moderate psoriasis patient randomize treatment group ( n=16 ) placebo group ( n=8 ) Study evaluation : A baseline end study evaluation patient perform , include physical examination , hemogram blood biochemical analysis ( include glutamic-oxaloacetic transaminase , glutamic-pyruvic transaminase , creatinine measurement ) . The baseline end study total body surface area involvement Psoriasis Area Severity Index ( PASI ) , PGA , OTPSS score also calculate .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>men woman age 20 65 year old least 6 month diagnosis moderate mild plaquetype psoriasis screening time study agent treatment Psoriasis Global Assessment ( PGA ) =23 , 20 % total body surface area ( BSA ) involve . , target plaque least 4 sq cm In good general health , evidence physical examination , hematology blood chemistry test within normal range exception liver function test value &lt; =1.5ULN If childbearing age , agreement continue use birth control measure duration study Patients agree participate sign consent form Patients agree return followup visit provide required biopsy . Currently nonplaque form psoriasis ( e.g. , erythrodermic , guttate , pustular psoriasis ) , rebound flare chronic plaque psoriasis Currently history psoriatic arthritis Have current druginduced psoriasis ( e.g. , new onset psoriasis exacerbation psoriasis beta blocker , calcium channel blocker , lithium ) . Are pregnant , nursing , plan pregnancy ( men woman ) enrol study . Have use biologic within previous 3 month 5 time halflife biologic , whichever longer Have receive phototherapy systemic treatment could affect psoriasis ( include , limited , ( eg , retinoids , methotrexate , cyclosporine , psoralens , sulfasalazine , hydroxyurea , fumaric acid derivative , herbal treatment traditional Chinese medicine ) within 4 week receive study treatment Have use topical treatment could affect psoriasis ( eg . corticosteroid tazarotene , tacrolimus , tar , anthralin , calcipotriene , topical vitamin D derivative , retinoids , tazarotene , methoxsalen , trimethylpsoralens , topical traditional Chinese medicine ) within 2 week receive study treatment Have use systemic immunosuppressant ( eg , MTX , azathioprine , cyclosporine , 6thioguanine , mercaptopurine , mycophenolate mofetil , hydroxyurea , tacrolimus ) within 4 week receive study treatment Are currently receive lithium , antimalarial , intramuscular gold , receive lithium , antimalarial , intramuscular gold within 4 week receive study treatment Positive screening test HIV , hepatitis B surface antigen , hepatitis C antibody A history alcohol drug abuse Clinically significant laboratory abnormality blood , renal function , liver function A history sensitivity Chinese herb , olive oil , yellow wax , petroleum jelly Have current sign symptom severe , progressive , uncontrolled renal , hepatic , hematological , gastrointestinal , endocrine , pulmonary , cardiac , neurologic , cerebral , psychiatric disease Be participate another trial use investigational agent procedure . Any condition view investigator , subject enrol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Indigo Naturalis</keyword>
	<keyword>chinese medicine</keyword>
</DOC>